Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. 1996

W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
University of Rochester School of Medicine and Dentistry, Department of Medicine, NY 14642, USA.

To assess the roles of pancreatic beta-cell (beta-cell) dysfunction and insulin resistance in the pathogenesis of non-insulin dependent diabetes mellitus, we used euglycaemic hyperinsulinaemic and hyperglycaemic clamps to compare insulin secretion and insulin sensitivity in Caucasian individuals of European ancestry with either normal glucose tolerance (NGT) or impaired glucose tolerance (IGT). Both groups were carefully matched for age, gender, obesity and body fat distribution. During the hyperglycaemic clamps, IGT had significantly lower first phase (650 +/- 60 vs 992 +/- 92 pmol l-1, p = 0.001) and second phase (231 +/- 24 vs 326 +/- 21 pmol l-1, p < 0.001) plasma insulin responses while their insulin sensitivity index (0.126 +/- 0.012 mumol kg-1 pM-1) was not significantly different from that of NGT (0.144 +/- 0.012 mumol kg-1 min-1 pM-1), p = 0.69). Similarly, during the euglycaemic hyperinsulinaemic clamps, the insulin sensitivity index of the IGT (0.076 +/- 0.005 mumol kg-1 min-1 pM-1) was not significantly different from that of the NGT (0.086 +/- 0.007 mumol kg-1 min-1 pM-1), p = 0.28. We conclude that since beta-cell dysfunction is already evident in people with impaired glucose tolerance but insulin resistance is not, impaired insulin secretion is most likely the primary genetic factor predisposing to the development of non-insulin dependent diabetes mellitus in Caucasians of European ancestry.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005060 Europe The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN. Northern Europe,Southern Europe,Western Europe
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
December 2022, Diabetes research and clinical practice,
W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
October 2010, Diabetologia,
W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
June 1994, Metabolism: clinical and experimental,
W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
January 1993, Experimental and clinical endocrinology,
W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
January 2005, Clinical endocrinology,
W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
February 2005, Nihon rinsho. Japanese journal of clinical medicine,
W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
October 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
November 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
W Pimenta, and A Mitrakou, and T Jensen, and H Yki-Järvinen, and G Daily, and J Gerich
September 1996, Diabetologia,
Copied contents to your clipboard!